top of page
![Pattern 5 [Converted]-01.png](https://static.wixstatic.com/media/51c62d_44f38c257d614130ace0f56455e9be12~mv2.png/v1/fill/w_49,h_36,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/51c62d_44f38c257d614130ace0f56455e9be12~mv2.png)
Knowledge Center
Search


HeartLung.AI Introduces Agatston 2.0: The next generation of calcium scoring hosted by SCCT
Agatston 2.0 and AI-CVD unveiled in a new SCCT-hosted webcast, showcasing the next generation of calcium scoring and cardiometabolic imaging. HOUSTON, TX, UNITED STATES, November 20, 2025 / EINPresswire.com / -- The Society of Cardiovascular Computed Tomography (SCCT) and HeartLung.AI today announced the release of a new sponsored webcast, “Agatston 2.0: The next generation of calcium scoring in the era of AI-CAC and AI-CVD.” The free webcast, sponsored by HeartLung.AI , br


HeartLung.AI Webcast
Hosted by Society of Cardiovascular Tomography (SCCT) Agatston 2.0: The next generation of calcium scoring in the era of AI-CAC and AI-CVD Full Video View Part 1 View Part 2 Webcast Summary Thirty years ago, the Agatston Score pioneered CT-based coronary atherosclerosis imaging. Since then, extensive evidence has established CAC as the strongest predictor of CHD events. However, two limitations have constrained its clinical utility: “Power of Zero” exceptions: Alth


HeartLung Technologies Sets New Milestone with Nine Accepted Abstracts at AHA 2025 Showcasing the Power of AI-CVD™
New Orleans, LA — October 21, 2025 — HeartLung Technologies today announced a record-setting presence at the upcoming American Heart Association (AHA) Scientific Sessions 2025, with nine peer-reviewed studies accepted for presentation—spotlighting breakthroughs from the company’s AI-CVD™ platform, including AI-CAC™ and novel CT-derived cardiometabolic imaging biomarkers. The work spans prediction of coronary “soft plaques”, heart failure, atrial fibrillation, COPD, non-zero


American Heart Association Cites HeartLung’s AI-CAC™ and AI-CVD™ Technologies in Landmark Scientific Statement on Opportunistic Screening
HOUSTON, TX — The American Heart Association (AHA) has released an official Scientific Statement in Circulation recognizing AI-enabled opportunistic detection of coronary artery calcium (CAC) on routine chest CT scans as an emerging cornerstone for cardiovascular disease prevention . The statement, titled “Opportunistic Detection of Coronary Artery Calcium on Noncardiac Chest Computed Tomography: An Emerging Tool for Cardiovascular Disease Prevention,” highlights the tr


AI-CVD Myosteatosis and Hepatosteatosis Findings Linked to Diabetes and Heart Failure Presented at Mount Sinai I-ELCAP Conference
FOR IMMEDIATE RELEASE New York, NY — October 10, 2025 Investigators from the AI-CVD™ consortium presented new results showing strong...


Mount Sinai Radiologist Presents New AutoBMD AI Data at I-ELCAP Showing High Rates of Previously Undetected Osteoporosis
FOR IMMEDIATE RELEASE New York, NY — October 9, 2025 New findings from Mount Sinai Hospital demonstrate hat AutoBMD™ AI can identify...


3DR Labs and HeartLung AI Integrate Opportunistic AI Tools for Bone and Cardiac Health
October 07, 2025 I Louisville, KY – 3DR Labs, the nation’s largest and most trusted provider of 3D medical image post-processing, today...


AI-CVD Investigators to Present at I-ELCAP’s 48th International Conference on Screening for Lung Cancer, October 9–11 in New York City
FOR IMMEDIATE RELEASE New York, NY — October 1, 2025 AI-CVD investigators will join global experts at the International Early Lung Cancer...


HeartLung.AI to Present Seven Pioneering AI-CVD™ and AI-CAC ™ Studies at European Society of Cardiology 2025 in Madrid
HeartLung AI will showcase seven abstracts at ESC 2025 on AI-CVD™, including novel AI-CAC™ for earlier, more sensitive heart disease...
bottom of page
